Prosecution Insights
Last updated: May 29, 2026

Examiner: OYEYEMI, OLAYINKA A

Tech Center 1600 • Art Units: 1637 1651 1681

This examiner grants 60% of resolved cases

Performance Statistics

60.5%
Allow Rate
+0.5% vs TC avg
483
Total Applications
+46.3%
Interview Lift
1263
Avg Prosecution Days
Based on 458 resolved cases, 2023–2026

Rejection Statute Breakdown

5.2%
§101 Eligibility
7.0%
§102 Novelty
59.2%
§103 Obviousness
11.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17518129 METHODS AND SYSTEMS FOR DETECTING PATHOGENIC MICROBES IN A PATIENT Non-Final OA ILLUMINA, INC.
17953878 BIOMARKERS COMPOSITION RELATED TO DIAGNOSIS AND PROGNOSIS OF IMMUNOGLOBULIN A NEPHROPATHY AND APPLICATION THEREOF Non-Final OA Zhejiang University
18053785 mecA GENE AMPLIFICATION PRIMER PAIR, mecA GENE DETECTION KIT AND mecA GENE DETECTION METHOD Non-Final OA MITSUI CHEMICALS, INC.
17708005 METHOD OF DIAGNOSING AND MONITORING SUBSTANCE ADDICTION OR BEHAVIORAL ADDICTION USING C-KIT BIOMARKER Non-Final OA Wuhan University
18658886 EFFICIENT DIGITAL MEASUREMENT OF LONG NUCLEIC ACID FRAGMENTS Non-Final OA Centre for Novostics
17677600 Combinatorial Microarray Assay for Detecting and Genotyping SARS-CoV-2 Non-Final OA University of Maryland, Baltimore
17361829 DETECTION OF TARGET NUCLEIC ACID AND VARIANTS Non-Final OA SAGA DIAGNOSTICS AB
17692236 PRIMER SET FOR DETECTING FOOD POISONING BACTERIA BY USING NEXT-GENERATION SEQUENCING METHOD AND METHOD FOR DETECTING FOOD POISONING BACTERIA BY USING THE PRIMER SET Final Rejection Korean Ministry of Food and Drug Safety
17456204 METHODS, COMPOSITIONS, KITS, AND USES FOR ANALYSIS OF NUCLEIC ACIDS COMPRISING REPEATING A/T-RICH SEGMENTS Final Rejection Asuragen, Inc.
17611545 NON-CODING RNA FOR SUBTYPING OF BLADDER CANCER Final Rejection Erasmus University Medical Center
17512713 METHOD FOR IDENTIFICATION OF URINE DRUG TESTING SAMPLE Non-Final OA ID Match, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month